Table 7.
1‐Year Follow‐up Clinical Outcomes
| No WRF | Transient WRF | Persistent WRF | P Value | |
|---|---|---|---|---|
| 3‐month mortality | ||||
| Total population | 109 (4.3) | 185 (10.0) | 145 (14.5) | <0.001 |
| HFrEF | 69 (5.2) | 106 (10.2) | 89 (15.3) | <0.001 |
| HFpEF | 24 (3.7) | 38 (9.0) | 28 (14.6) | <0.001 |
| 1‐year mortality | ||||
| Total population | 298 (11.9) | 407 (22.0) | 265 (26.6) | <0.001 |
| HFrEF | 161 (12.1) | 224 (21.5) | 157 (26.9) | <0.001 |
| HFpEF | 74 (11.5) | 93 (21.9) | 48 (25.0) | <0.001 |
Values are expressed in n (%). HFpEF indicates heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; WRF, worsening renal function.